Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 348,057 |
|
|||||
| News | - | ||||||
| Day High | 2.78 | Low High |
|||||
| Day Low | 2.735 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -1.45% | 2.71 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.75 | 2.735 | 2.78 | 2.74 | 2.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,582 | 348,057 | $ 2.75 | $ 957,393 | - | 1.69 - 3.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:51:39 | formt | 618 | $ 2.71 | USD |
Arbutus Biopharma Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 491.81M | 179.49M | - | 18.14M | -72.85M | -0.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arbutus Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.91 | 2.9377 | 2.635 | 2.73 | 897,331 | -0.20 | -6.87% |
| 1 Month | 2.49 | 3.29 | 2.30 | 2.94 | 2,228,035 | 0.22 | 8.84% |
| 3 Months | 2.46 | 3.29 | 2.265 | 2.82 | 1,452,757 | 0.25 | 10.16% |
| 6 Months | 1.70 | 3.29 | 1.69 | 2.58 | 1,059,496 | 1.01 | 59.41% |
| 1 Year | 3.00 | 3.29 | 1.69 | 2.45 | 840,308 | -0.29 | -9.67% |
| 3 Years | 3.23 | 6.50 | 1.69 | 3.50 | 1,939,471 | -0.52 | -16.10% |
| 5 Years | 3.01 | 9.00 | 0.81 | 3.66 | 2,065,949 | -0.30 | -9.97% |
Arbutus Biopharma Description
| Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. |
